JP Stock MarketDetailed Quotes

4528 Ono Pharmaceutical

Watchlist
  • 1958.0
  • 0.00.00%
20min DelayMarket to Open Nov 1 15:00 JST
976.44BMarket Cap7.35P/E (Static)

Ono Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
-1.95%117.68B
12.41%502.67B
4.25%112.77B
7.25%131.19B
26.11%138.7B
12.46%120.02B
23.75%447.19B
20.28%108.17B
25.64%122.32B
26.83%109.98B
Cost of revenue
-1.66%29.67B
15.50%127.13B
20.51%31.66B
2.07%30.7B
29.20%34.59B
12.01%30.17B
17.70%110.06B
14.85%26.28B
19.98%30.08B
17.60%26.78B
Gross profit
-2.05%88B
11.40%375.55B
-0.96%81.11B
8.94%100.49B
25.12%104.1B
12.61%89.84B
25.86%337.12B
22.13%81.89B
27.61%92.24B
30.12%83.21B
Operating expense
18.18%57.32B
10.48%215.61B
5.24%65.8B
5.96%52.9B
17.81%48.42B
16.51%48.5B
18.53%195.16B
35.83%62.52B
3.39%49.93B
15.55%41.1B
Selling and administrative expenses
18.75%27.89B
12.05%100.27B
15.58%26.98B
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
13.46%21.22B
-General and administrative expense
18.75%27.89B
12.05%100.27B
15.58%26.98B
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
13.46%21.22B
Research and development costs
17.41%28.86B
17.65%112.17B
21.49%35.68B
2.98%27.13B
22.58%24.78B
26.61%24.58B
25.65%95.34B
11.19%29.37B
55.78%26.35B
16.81%20.22B
Other operating expenses
10.13%609M
-60.75%4.34B
-66.72%3.34B
-62.33%165M
2,308.33%289M
-6.27%553M
-12.86%11.07B
3,531.88%10.02B
-96.23%438M
-70.00%12M
Total other operating income
-68.64%37M
60.22%1.18B
-8.80%197M
39.34%85M
121.08%776M
11.32%118M
-25.10%734M
-8.09%216M
-19.74%61M
-27.03%351M
Operating profit
-25.78%30.69B
12.66%159.94B
-20.97%15.31B
12.46%47.59B
32.25%55.69B
8.35%41.35B
37.57%141.96B
-7.87%19.37B
76.37%42.32B
48.38%42.11B
Net non-operating interest income (expenses)
153.88%2.62B
142.68%3.8B
616.36%1.14B
-60.96%406M
1,013.43%1.22B
17.27%1.03B
-14.76%1.57B
36.78%-220M
-7.39%1.04B
-385.11%-134M
Non-operating interest income
111.70%2.7B
62.51%4.03B
1,214.49%907M
27.59%1.51B
1,813.85%1.24B
9.84%1.27B
-8.56%2.48B
-60.12%69M
5.52%1.19B
-38.10%65M
Non-operating interest expense
-68.88%75M
-74.92%229M
-179.24%-229M
662.76%1.11B
-89.95%20M
-13.62%241M
4.46%913M
-44.53%289M
--145M
243.10%199M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0
-75.00%1M
-3M
0
100.00%6M
-2M
166.67%4M
0
1M
3M
Special income (charges)
Other non-operating income (expenses)
Income before tax
-21.40%33.31B
14.07%163.73B
-14.15%16.44B
10.69%48B
35.59%56.92B
8.55%42.38B
36.66%143.53B
-7.37%19.15B
72.63%43.36B
47.67%41.98B
Income tax
-19.75%8.47B
16.57%35.69B
-147.78%-988M
19.36%11.91B
56.84%14.22B
11.01%10.56B
25.80%30.62B
-55.62%2.07B
47.06%9.98B
46.19%9.06B
Net income
-21.95%24.84B
13.40%128.04B
2.01%17.43B
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.69%17.09B
82.08%33.39B
48.09%32.91B
Net income continuous operations
-21.94%24.84B
13.40%128.04B
2.02%17.43B
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.67%17.09B
82.08%33.39B
48.09%32.91B
Noncontrolling interests
42M
-67.37%62M
-122.22%-4M
-45.59%37M
-44.23%29M
0
14.46%190M
-84.75%18M
1,260.00%68M
420.00%52M
Net income attributable to the company
-22.08%24.79B
13.53%127.98B
2.14%17.43B
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
47.92%32.86B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-22.08%24.79B
13.53%127.98B
2.14%17.43B
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
47.92%32.86B
Gross dividend payment
Basic earnings per share
-18.98%52.79
15.49%266.61
7.38%37.53
11.05%75.77
31.03%88.18
7.93%65.16
42.33%230.85
7.27%34.95
85.26%68.23
51.20%67.3
Diluted earnings per share
-19.03%52.75
15.50%266.57
7.45%37.51
11.05%75.76
31.03%88.18
7.94%65.15
42.32%230.79
7.18%34.91
85.28%68.22
51.24%67.3
Dividend per share
0
14.29%80
8.11%40
0
21.21%40
0
25.00%70
32.14%37
0
17.86%33
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue -1.95%117.68B12.41%502.67B4.25%112.77B7.25%131.19B26.11%138.7B12.46%120.02B23.75%447.19B20.28%108.17B25.64%122.32B26.83%109.98B
Cost of revenue -1.66%29.67B15.50%127.13B20.51%31.66B2.07%30.7B29.20%34.59B12.01%30.17B17.70%110.06B14.85%26.28B19.98%30.08B17.60%26.78B
Gross profit -2.05%88B11.40%375.55B-0.96%81.11B8.94%100.49B25.12%104.1B12.61%89.84B25.86%337.12B22.13%81.89B27.61%92.24B30.12%83.21B
Operating expense 18.18%57.32B10.48%215.61B5.24%65.8B5.96%52.9B17.81%48.42B16.51%48.5B18.53%195.16B35.83%62.52B3.39%49.93B15.55%41.1B
Selling and administrative expenses 18.75%27.89B12.05%100.27B15.58%26.98B10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B13.46%21.22B
-General and administrative expense 18.75%27.89B12.05%100.27B15.58%26.98B10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B13.46%21.22B
Research and development costs 17.41%28.86B17.65%112.17B21.49%35.68B2.98%27.13B22.58%24.78B26.61%24.58B25.65%95.34B11.19%29.37B55.78%26.35B16.81%20.22B
Other operating expenses 10.13%609M-60.75%4.34B-66.72%3.34B-62.33%165M2,308.33%289M-6.27%553M-12.86%11.07B3,531.88%10.02B-96.23%438M-70.00%12M
Total other operating income -68.64%37M60.22%1.18B-8.80%197M39.34%85M121.08%776M11.32%118M-25.10%734M-8.09%216M-19.74%61M-27.03%351M
Operating profit -25.78%30.69B12.66%159.94B-20.97%15.31B12.46%47.59B32.25%55.69B8.35%41.35B37.57%141.96B-7.87%19.37B76.37%42.32B48.38%42.11B
Net non-operating interest income (expenses) 153.88%2.62B142.68%3.8B616.36%1.14B-60.96%406M1,013.43%1.22B17.27%1.03B-14.76%1.57B36.78%-220M-7.39%1.04B-385.11%-134M
Non-operating interest income 111.70%2.7B62.51%4.03B1,214.49%907M27.59%1.51B1,813.85%1.24B9.84%1.27B-8.56%2.48B-60.12%69M5.52%1.19B-38.10%65M
Non-operating interest expense -68.88%75M-74.92%229M-179.24%-229M662.76%1.11B-89.95%20M-13.62%241M4.46%913M-44.53%289M--145M243.10%199M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 0-75.00%1M-3M0100.00%6M-2M166.67%4M01M3M
Special income (charges)
Other non-operating income (expenses)
Income before tax -21.40%33.31B14.07%163.73B-14.15%16.44B10.69%48B35.59%56.92B8.55%42.38B36.66%143.53B-7.37%19.15B72.63%43.36B47.67%41.98B
Income tax -19.75%8.47B16.57%35.69B-147.78%-988M19.36%11.91B56.84%14.22B11.01%10.56B25.80%30.62B-55.62%2.07B47.06%9.98B46.19%9.06B
Net income -21.95%24.84B13.40%128.04B2.01%17.43B8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.69%17.09B82.08%33.39B48.09%32.91B
Net income continuous operations -21.94%24.84B13.40%128.04B2.02%17.43B8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.67%17.09B82.08%33.39B48.09%32.91B
Noncontrolling interests 42M-67.37%62M-122.22%-4M-45.59%37M-44.23%29M014.46%190M-84.75%18M1,260.00%68M420.00%52M
Net income attributable to the company -22.08%24.79B13.53%127.98B2.14%17.43B8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B47.92%32.86B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -22.08%24.79B13.53%127.98B2.14%17.43B8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B47.92%32.86B
Gross dividend payment
Basic earnings per share -18.98%52.7915.49%266.617.38%37.5311.05%75.7731.03%88.187.93%65.1642.33%230.857.27%34.9585.26%68.2351.20%67.3
Diluted earnings per share -19.03%52.7515.50%266.577.45%37.5111.05%75.7631.03%88.187.94%65.1542.32%230.797.18%34.9185.28%68.2251.24%67.3
Dividend per share 014.29%808.11%40021.21%40025.00%7032.14%37017.86%33
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data